Background: New genomic technology now allows physicians to provide women with
individualized and highly accurate breast cancer recurrence risk estimates that are a key …

Background. As new genomic technology expands the number of medical tests available to
physicians and patients, identifying gaps in our understanding of how best to communicate …

Background: Genomic recurrence risk test results now inform clinical decisions about
adjuvant treatment for women with early‐stage breast cancer. We sought to understand …

Doctors commonly use genomic testing for breast cancer recurrence risk. We sought to
assess whether the standard genomic report provided to doctors is a good approach for …

Abstract Background/Aims: Our study examined whether patient characteristics, beliefs and
decision-making styles were associated with uptake of genomic testing for breast cancer …

Purpose Genomic and other technologies are improving the accuracy with which clinicians
can estimate risk for recurrence (RFR) of breast cancer and make judgments about potential …

BACKGROUND: Few studies have examined how patients understand and use genomic
test results when deciding about treatment. This study examined how women receive and …

Recent scientific breakthroughs in the genetics of breast cancer may have had effects on
women's perceptions of risk and subsequent worry about breast cancer. Here, we present …

The growing importance of genome sequencing means that patients will increasingly face
decisions regarding what results they would like to learn. The present study examined …

Background Informed consent is an essential component of medical practice, and especially
so in procedural based specialties which entail varying degrees of risk. Breast cancer is one …